Ghana's healthcare system occupies a distinct position in West Africa. It is more organised than most of its regional peers, it implemented the continent's first broad-based national health insurance scheme in 2003, and it has produced internationally recognised research institutions and clinical training capacity. At the same time, it faces challenges familiar across sub-Saharan Africa: underfunded public facilities, a growing non-communicable disease burden, a maldistributed health workforce, and a digital health sector that has generated significant innovation without fully connecting to the national health information architecture. For sponsors, investors, and health organisations evaluating Ghana, the system's strengths and constraints are equally important.
Ghana's healthcare system at a glance
The Ghana healthcare system operates through a tiered structure coordinated by the Ghana Health Service (GHS) and the Ministry of Health. The GHS is responsible for policy implementation, facility management, and public health programmes across the country's 16 regions.
Key indicators for 2024 or most recent available data:
- Population: approximately 34.4 million (Ghana Statistical Service 2024 projection)
- Life expectancy at birth: 63.9 years (World Bank 2022)
- Under-5 mortality rate: 42.3 per 1,000 live births (World Bank / WHO 2022)
- Physician density: approximately 0.14 per 1,000 population (WHO Global Health Observatory)
- Total health expenditure as share of GDP: approximately 3.9 percent (WHO 2021)
- NHIS active membership: approximately 15 to 17 million (NHIA 2022–2023)
- HIV prevalence: 1.53 percent among adults aged 15 to 49 (Ghana AIDS Commission 2023)
The public health facility network is organised across four levels: teaching hospitals (Korle Bu, Komfo Anokye, Tamale Teaching Hospital), regional hospitals (one per region), district hospitals, and Community-based Health Planning and Services (CHPS) compounds. CHPS compounds are the primary care access point for rural populations, staffed by community health officers and community health volunteers.
The private sector, comprising private hospitals, clinics, maternity homes, and pharmacy chains, provides approximately 30 to 40 percent of outpatient care, concentrated in urban centres. Faith-based health facilities, coordinated through the Christian Health Association of Ghana (CHAG) and the Muslim Health Mission, operate approximately 30 percent of health facilities outside the public sector and serve significant rural populations.
The National Health Insurance Scheme
The National Health Insurance Scheme (NHIS Ghana) is one of Africa's most watched health financing experiments. Established by the National Health Insurance Act (Act 650) of 2003 and revised under Act 852 of 2012, the NHIS was designed to replace a cash-and-carry system in which patients had to pay for services at the point of care, a barrier that caused many Ghanaians to delay or forgo treatment.
The NHIS is funded through three sources: a 2.5 percent levy on VAT, a 2.5 percent contribution from Social Security and National Insurance Trust (SSNIT) contributors, and annual premiums from members not covered by SSNIT (self-employed, informal workers, and others). Exempt groups (children under 18, pregnant women, elderly individuals above 70, and the very poor) receive membership without premium payment.
The scheme covers a benefit package that includes outpatient care, inpatient care (excluding some expensive procedures), medicines on the NHIS Essential Medicines List, and some diagnostic services. The benefit package has been described as relatively generous by low-income country standards, but reimbursement rates to providers are often lower than actual service costs, creating sustainability pressures.
Active NHIS membership fluctuates significantly based on premium collection efficiency and renewal rates. The National Health Insurance Authority (NHIA) has reported active membership of between 15 and 17 million at various points in recent years, roughly 45 to 55 percent of the population. Actual utilisation among registered members is lower, partly because card verification systems at facilities have historically been unreliable.
The NHIA has been investing in digital systems to improve membership verification, claims processing, and fraud detection. A biometric registration system and a mobile NHIS card have been deployed to reduce ghost membership and improve claims accuracy. These digital investments are also generating structured administrative data with significant health research value. Platforms like Kapsule aggregate de-identified patient records from facilities across Ghana and eight other African countries, making this data accessible for research and market analysis.
Health infrastructure: from CHPS to teaching hospitals
Ghana's CHPS (Community-based Health Planning and Services) programme is one of the country's most distinctive health system innovations. Launched in the 1990s and scaled nationally from the 2000s, CHPS places community health workers at designated CHPS compounds, small health outposts, in rural communities without access to clinics or hospitals.
Ghana operates a significant network of CHPS compounds across the country; reported figures range from approximately 5,000 to over 6,500 in recent years, though exact current counts vary by source and reporting period. Each compound is staffed by community health officers who provide basic curative care, antenatal services, child health monitoring, immunisation, and health education. CHPS workers also conduct household visits, making it one of Africa's more intensive community health worker models.
District hospitals, one per district, are the primary referral facilities for CHPS communities. As of 2022, Ghana had 261 districts with varying levels of hospital coverage. District hospital capacity varies considerably: well-resourced districts near major cities have hospitals with laboratory, radiology, and surgical capacity; remote districts in the Northern, Upper East, and Upper West regions operate with far more limited facilities.
At the apex of the system, Korle Bu Teaching Hospital in Accra and Komfo Anokye Teaching Hospital in Kumasi are the country's two largest public referral hospitals. Korle Bu has approximately 2,000 beds and provides tertiary care across virtually all specialties. Both hospitals are affiliated with major Ghanaian medical schools and have active clinical research programmes.
Zipline, the drone delivery company, operates the world's largest medical drone delivery service from Ghana. Launched in 2019 under a government contract, Zipline's network of six distribution centres delivers blood products, vaccines, and essential medicines to over 2,500 health facilities across the country. By 2023, Zipline had completed over 370,000 cumulative deliveries across six distribution centres in Ghana, demonstrating that logistics innovation can address supply chain gaps that conventional infrastructure cannot.
Disease burden and public health priorities
Ghana's disease burden has undergone a significant epidemiological transition over the past two decades. Infectious diseases (malaria, lower respiratory infections, diarrhoeal diseases) remain major causes of morbidity and mortality but have declined as a share of the total burden as non-communicable diseases have grown.
Malaria is still the leading cause of outpatient visits, responsible for approximately 35 to 40 percent of all outpatient attendances at public facilities, according to GHS Annual Report data. Ghana accounts for approximately 2.5 percent of global malaria cases. The national malaria programme has deployed indoor residual spraying, insecticide-treated nets, and artemisinin-based combination therapies widely, but malaria burden reduction has been slower than in some regional peers.
Non-communicable diseases now account for an estimated 43 percent of all deaths in Ghana (WHO, 2022 country profile). Hypertension affects an estimated 25 to 30 percent of adults. Diabetes prevalence is approximately 3 to 4 percent of the adult population but growing. Cancers (cervical, breast, prostate, and liver cancer) are significant causes of mortality with limited early detection capacity in the public sector. Road traffic injuries are a major contributor to disability-adjusted life years.
Maternal and child health indicators have improved substantially since 2000 but remain below Ghana's aspirational targets. The maternal mortality ratio was 308 per 100,000 live births as of the 2022 WHO estimates, improved from approximately 540 in 2000 but still far above the SDG target of below 70. NHIS exemption for pregnant women has significantly increased antenatal care attendance and facility delivery rates since it was introduced.
Digital health in Ghana
Digital health in Ghana has been shaped by both government investment and a growing private innovation ecosystem. The Ministry of Health has maintained DHIS2 as the backbone of national health data reporting, with facility-level data flowing from CHPS compounds through district offices to the national level. Coverage and data quality have improved over successive reporting cycles, though completeness remains a challenge in some districts.
The Ghana Health Service Digital Strategy 2020–2024 set targets for EMR adoption in district hospitals and above, telehealth integration, and national health ID implementation. Progress against these targets has been uneven, with urban facilities advancing faster than rural ones.
In the private sector, several home-grown digital health companies have achieved scale. mPharma Ghana, one of Africa's leading pharmacy tech companies, is headquartered in Accra and manages drug procurement and inventory for hospital networks and pharmacies across nine African countries. Its operations generate structured data on drug dispensing patterns that have research and market intelligence value.
Telehealth adoption accelerated during COVID-19 and has been sustained through platforms including Sproxil (medicine verification), Redbird (diagnostics), and several telemedicine startups targeting urban insured populations. Regulatory clarity for telehealth practice remains partial; the Ghana Medical and Dental Council has issued interim guidance but formal telehealth regulations are still in development.
The Ghana FDA (Food and Drugs Authority), distinct from NAFDAC in Nigeria, regulates clinical trials, medical devices, and investigational products. The Ghana FDA has been modernising its clinical trial review process, with expedited review timelines of approximately 90 days for eligible applications. The Council for Scientific and Industrial Research (CSIR) and the Ghana Health Service's institutional review boards provide ethics oversight.
Clinical research capacity
Ghana's clinical research infrastructure is concentrated in Accra and Kumasi but has national reach through GHS-affiliated institutions.
The Noguchi Memorial Institute for Medical Research (NMIMR) at the University of Ghana is the country's primary biomedical research institute. It has participated in major international trials in malaria, HIV, typhoid, and other infectious diseases, and hosts BSL-3 laboratory capacity.
Kintampo Health Research Centre in Brong-Ahafo (now Bono East Region) is one of Africa's longest-running research sites, with expertise in malaria, child health, and rural health systems research. Its longitudinal health and demographic surveillance system (HDSS) has generated decades of population health data.
Komfo Anokye Teaching Hospital in Kumasi and Korle Bu in Accra both have active clinical research units and ethics review boards. Several international CROs maintain country offices or partnerships in Ghana, facilitating multi-country trial operations across West Africa.
Ghana's geographic and ethnic diversity, spanning more than 70 ethnic groups from Akan, Mole-Dagbani, Ewe, Ga-Dangbe, and other groups, provides a research population with genetic diversity that complements single-ethnicity cohorts from larger but less diverse studies.
Opportunities for sponsors and health organisations
Ghana's health system offers several distinct advantages for international organisations:
Infectious disease and vaccine research. The Noguchi Institute and Kintampo Centre have decades of expertise and established community research relationships. Vaccine trials, including malaria, typhoid, and meningitis, have been conducted successfully at scale.
NHI data and administrative records. The NHIA's claims database and membership records, though not yet fully digitised or accessible for research, represent a growing asset. As digital systems mature, NHIS claims data could provide population-scale treatment pattern information for insured members.
NCD research platform. Ghana's growing NCD burden and its established clinical research capacity create an underutilised platform for cardiovascular, metabolic, and oncology research. Patient populations are often younger and less medicated than equivalent Western cohorts, making them valuable for pharmacological studies.
Regional hub positioning. Ghana's political stability, English-language governance, and relatively developed infrastructure make it a natural hub for West Africa regional operations. For sponsors planning multi-country West African programmes, Ghana often serves as the primary logistics, regulatory, and operational base, alongside work in Nigeria for volume.
Kapsule provides access to structured, de-identified health records covering over 75 million patients across 9 African countries. Contact our team to discuss how Ghanaian health data can inform your clinical trial planning, market assessment, or public health research.
This article is intended for informational purposes only and does not constitute legal, medical, or regulatory advice. Readers should obtain independent professional counsel for their specific circumstances.